Franco Trevisani

26PUBLICATIONS
102CO-AUTHORS
Haematological tumoursPredictive and prognostic markersCardiology (incl. cardiovascular diseases)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (26)

|Jan 08, 2025
Absence of Viral Replication Is Associated With Improved Outcome in Anti-HCV-Positive Patients With Hepatocellular Carcinoma.

Edoardo G Giannini, Andrea Pasta, Maria Corina Plaz Torres

|Mar 28, 2024
Impact of Sarcopenia on the Survival of Patients with Hepatocellular Carcinoma Treated with Sorafenib.

Maurizio Biselli, Nicola Reggidori, Massimo Iavarone

|Mar 01, 2024
Characteristics and outcome of anti-hepatitis D virus positive patients with hepatocellular carcinoma.

Edoardo G Giannini, Andrea Pasta, Giulia Pieri

|Jan 26, 2024
Comparative Analysis of Subclassification Systems in Patients with Intermediate-Stage Hepatocellular Carcinoma (Barcelona Clinic Liver Classification B) Receiving Systemic Therapy.

Luca Ielasi, Bernardo Stefanini, Fabio Conti

|Sep 27, 2023
Predictors of non-transplantable recurrence in hepatocellular carcinoma patients treated with frontline liver resection.

Filippo Pelizzaro, Franco Trevisani, Vittorio Simeon

|May 16, 2023
Immune Checkpoint Inhibitors in Hepatocellular Carcinoma: Current Strategies and Biomarkers Predicting Response and/or Resistance.

Filippo Pelizzaro, Fabio Farinati, Franco Trevisani

Pageof 5

Frequent Collaborators

11 joint publications

Fabio Piscaglia

11 joint publications

Edoardo Giovanni Giannini

9 joint publications

Rodolfo Sacco

8 joint publications

Gianpaolo Vidili